Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:14 pm Purchase |
2024-12-31 | 13G | Sanofi SNY |
Amundi S.A. | 64,334,393 5.100% |
64,334,393 (New Position) |
Filing History |
| 2024-11-07 2:49 pm Purchase |
2024-09-30 | 13G | Sanofi SNY |
Amundi S.A. | 64,569,630 5.100% |
943,853 (+1.48%) |
Filing History |
| 2024-08-13 09:06 am Purchase |
2024-08-12 | 13G | MeiraGTx Holdings plc MGTX |
SANOFI SYNTHELABO SA | 12,197,737 15.800% |
7,500,000 (+159.65%) |
Filing History |
| 2024-05-31 4:30 pm Purchase |
2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX |
SANOFI SYNTHELABO SA | 1,157,926 8.000% |
1,157,926 (New Position) |
Filing History |
| 2024-02-14 3:57 pm Purchase |
2023-12-31 | 13G | Sanofi SNY |
Amundi S.A. | 63,625,777 5.000% |
63,625,777 (New Position) |
Filing History |
| 2024-02-13 1:55 pm Sale |
2023-12-31 | 13G | Sanofi SNY |
DODGE & COX | 78,250,193 4.900% |
-5,938,881 (-7.05%) |
Filing History |
| 2024-02-06 3:14 pm Sale |
2023-12-31 | 13G | Sanofi SNY |
BLACKROCK INC BLK |
90,493,241 7.200% |
-1,201,819 (-1.31%) |
Filing |
| 2023-11-06 07:50 am Purchase |
2023-10-30 | 13G | MeiraGTx Holdings plc MGTX |
SANOFI SYNTHELABO SA | 4,697,737 7.400% |
4,697,737 (New Position) |
Filing History |
| 2023-02-14 2:22 pm Sale |
2022-12-31 | 13G | Sanofi SNY |
DODGE & COX | 84,189,074 5.300% |
-9,212,975 (-9.86%) |
Filing History |
| 2023-02-10 4:49 pm Sale |
2022-12-31 | 13G | Sanofi SNY |
Amundi S.A. | 65,432,736 5.200% |
-5,928,109 (-8.31%) |
Filing |
| 2023-02-07 2:10 pm Sale |
2022-12-31 | 13G | Sanofi SNY |
BLACKROCK INC BLK |
91,695,060 7.200% |
-1,389,360 (-1.49%) |
Filing |
| 2022-02-22 12:04 pm Purchase |
2021-12-31 | 13G | Sanofi SNY |
Amundi S.A. | 71,360,845 5.700% |
23,797,608 (+50.03%) |
Filing |
| 2022-02-15 08:17 am Sale |
2021-12-31 | 13G | Sanofi SNY |
Amundi S.A. | 47,563,237 3.800% |
-15,754,906 (-24.88%) |
Filing |
| 2022-02-14 1:29 pm Purchase |
2021-12-31 | 13G | Sanofi SNY |
DODGE & COX | 93,402,049 5.600% |
93,402,049 (New Position) |
Filing History |
| 2022-02-08 08:27 am Purchase |
2021-08-02 | 13G | Icosavax, Inc. ICVX |
SANOFI SYNTHELABO SA | 3,155,169 8.080% |
3,155,169 (New Position) |
Filing History |
| 2022-02-03 4:29 pm Sale |
2021-12-31 | 13G | Sanofi SNY |
BLACKROCK INC BLK |
93,084,420 7.400% |
-767,112 (-0.82%) |
Filing |
| 2021-08-12 4:00 pm Sale |
2021-08-02 | 13D | Telesis Bio, Inc. TBIO |
SANOFI SYNTHELABO SA | 204,691 4.900% |
-66,667 (-24.57%) |
Filing History |
| 2021-03-31 11:19 am Purchase |
2021-03-25 | 13G | LAVA Therapeutics N.V. LVTX |
SANOFI SYNTHELABO SA | 1,919,455 7.000% |
1,919,455 (New Position) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Sanofi SNY |
Amundi S.A. | 63,318,143 5.000% |
63,318,143 (New Position) |
Filing |
| 2021-02-11 10:46 am Purchase |
2020-02-13 | 13G | Fulcrum Therapeutics, Inc. FULC |
SANOFI SYNTHELABO SA | 3,363,050 4.600% |
3,363,050 (New Position) |
Filing History |